Panlin Capital Announces Second Closing for its Healthcare Venture Capital Fund; Has Raised a Total of RMB 1.5 Billion in the Last Two Years

Posted on by

SHANGHAI, Dec. 25, 2023 /PRNewswire/ — Recently, Panlin Capital announced that Hangzhou Panlin Xukang Fund, a venture capital fund focusing on innovative biopharmaceuticals, innovative medical device and biotechnology, has completed its second closing. This is the first fund that Panlin…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.